You are trying to load the Human Atlas. Either you do not have the newest version of Adobe Flash®, or you have JavaScript disabled, both of which are required to use this system.
With access to 900+ MedStar Georgetown University Hospital physicians, our nurse counselors can schedule your appointment or referral, and provide you with insightful information about our expert physicians.
Call us today at 202-342-2400 or toll free at 866-745-2633 Monday–Friday from 8 a.m.–8 p.m.
Please click here for more information.
Pulmonary nocardiosis is an infection of the lung with the bacteria, Nocardia asteroides.
Alternative Names:
Nocardiosis - pulmonary
Causes, incidence, and risk factors:
Nocardia infection develops when you breathe in (inhale) the bacteria. The infection causes pneumonia -like symptoms. The infection can spread to any part of the body.
People at highest risk for nocardia infection are those with a weakened immune system. This includes people who have:
Been taking steroids or other medicines that weaken the immune system for a long time
Signs and tests: Your doctor or nurse will examine you and listen to your lungs using a stethoscope. You may have abnormal lung sounds, called crackles. Tests that may be done include:
Bronchoalveolar lavage - fluid is sent for stain and culture
The goal of treatment is to control the infection. Antibiotics are used, but it may take a while to get better. You must keep taking the medications for at least 3 months.
Surgery may be needed to remove or drain infected areas.
Your health care provider may tell you to stop taking any medicines that weaken your immune system. Never stop taking any medicine before talking to your health provider first.
Support Groups:
Expectations (prognosis):
The outcome is often good when diagnosed and treated quickly.,
The outcome is poor when the infection spreads outside the lung, treatment is delayed, or the patient has serious underlying diseases.
Review Date: 8/30/2012 Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Denis Hadjiliadis, MD, Assistant Professor of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania, Philadelphia, PA. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.